Photodynamic Therapy in Treating Patients With Refractory Mycosis Fungoides
Status:
Completed
Trial end date:
2020-08-12
Target enrollment:
Participant gender:
Summary
This pilot phase II trial studies how well photodynamic therapy works in treating patients
with mycosis fungoides that does not respond to treatment. Photodynamic therapy uses a drug,
such as aminolevulinic acid hydrochloride, that becomes active when it is exposed to light.
The activated drug may kill cancer cells.